Very long chain fatty acid levels in patients diagnosed with multiple sclerosis

Multiple Sclerosis

Volumn 15, Issue 12, 2009, Pages 1525-1527

  Wilkins, Alastair ^a   Ingram, Gillian ^b   Brown, Anny ^c   Jardine, Philip ^d   Steward, Colin G ^d   Robertson, Neil P ^b   Scolding, Neil J ^a  

^a FRENCHAY HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

^d Royal Hospital for Children   (United Kingdom)

Author keywords

Genetics; Multiple sclerosis

Indexed keywords

VERY LONG CHAIN FATTY ACID;

ADRENOLEUKODYSTROPHY; ADULT; ARTICLE; BLOOD SAMPLING; DIAGNOSTIC VALUE; DISEASE COURSE; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; RELATIVE;

ADRENOLEUKODYSTROPHY; ADULT; BIOLOGICAL MARKERS; FATTY ACIDS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; PEDIGREE; PHENOTYPE;

EID: 72749088002     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509351731     Document Type: Article

References (10)

1. Moser HW, Mahmood A., Raymond GV X-linked adrenoleukodystrophy. Nat Clin Pract Neurol 2007 ; 3: 140-151.
2. Costello DJ, Eichler FS, Grant PE, Auluck PK Case records of the Massachusetts General Hospital. Case 1-2009. A 57-year-old man with progressive cognitive decline. N Engl J Med 2009 ; 360: 171-181.
3. OBrien TJ, Gates PG, Byrne E. Symptomatic female heterozygotes for adrenoleucodystrophy: a report of two unrelated cases and a review of the literature. J Clin Neurosci 1996 ; 3: 166-170.
4. Trojano M., Paolicalli D. The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes. Neurol Sci 2001 ; 22: S98 - S102.
5. McDonald WI, Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001 ; 50: 121-127.
6. Poser CM, Paty DW, Scheinberg L., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983 ; 13: 227-231.
7. Van Geel BM, Assies J., Weverling GJ, Barth PG Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in The Netherlands: a survey of 30 kindreds. Neurology 1994 ; 44: 2343-2346.
8. Eichler F., Mahmood A., Loes D., et al. Magnetic resonance imaging detection of lesion progression in adult patients with X-linked adrenoleukodystrophy. Arch Neurol 2007 ; 64: 659-664.
9. Kemp S., Wanders RJ X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment. Mol Genet Metab 2007 ; 90: 268-276.
10. Stradomska TJ, Tylki-SzymaÅ,ska A. Decreasing serum VLCFA levels in ageing X-ALD female carriers. J Inherit Metab Dis 2001 ; 24: 851-857.